Blood condition linked to worse heart attack outcomes?
NCT ID NCT07615023
First seen May 30, 2026 · Last updated Jun 06, 2026 · Updated 1 time
Summary
This study explores whether a common, age-related blood condition called CHIP (Clonal Hematopoiesis of Indeterminate Potential) leads to more severe heart damage in people who have a major heart attack (STEMI). Researchers will enroll 350 patients aged 18-75 and use advanced imaging and genetic testing to measure heart injury and track recovery over 4 years. The goal is to understand why some patients fare worse than others, which could guide future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Medical University of Innsbruck
Innsbruck, Tyrol, 6020, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.